Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy of first‐line dual oral pyrotinib plus capetabin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy of first‐line dual oral pyrotinib plus capetabine therapy in HER2‐positive metastatic breast cancer: A real‐world retrospective study
0
Authors
Shuang Dai
4 more
Shuang Dai
•
Yong Zhang
2 more
•
Xi Yan
Published
May 29, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Medicine
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Metastatic Breast Cancer
Show all topics
DOI
10.1002/cam4.7256
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Medicine
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Metastatic Breast Cancer
Show all topics
DOI
10.1002/cam4.7256
License
CC-BY
